Genprex, Inc. (LON: 0A8I)

Genprex Statistics

Total Valuation

Genprex has a market cap or net worth of GBP 5.19 million. The enterprise value is 3.99 million.

Market Cap	5.19M
Enterprise Value	3.99M

Important Dates

The next estimated earnings date is Monday, March 31, 2025.

Earnings Date	Mar 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+69.37%
Shares Change (QoQ)	+61.88%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	8.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	4.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.24
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.86

Current Ratio	0.86
Quick Ratio	0.66
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -325.11% and return on invested capital (ROIC) is -204.23%.

Return on Equity (ROE)	-325.11%
Return on Assets (ROA)	-138.83%
Return on Capital (ROIC)	-204.23%
Revenue Per Employee	n/a
Profits Per Employee	-891,784
Employee Count	26
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -91.39% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-91.39%
50-Day Moving Average	1.11
200-Day Moving Average	5.21
Relative Strength Index (RSI)	38.63
Average Volume (20 Days)	6,432

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.21

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-17.03M
Pretax Income	-16.94M
Net Income	-16.94M
EBITDA	-17.02M
EBIT	-17.03M
Earnings Per Share (EPS)	-7.72

Balance Sheet

Cash & Cash Equivalents	1.11M
Total Debt	n/a
Net Cash	1.11M
Net Cash Per Share	n/a
Equity (Book Value)	1.24M
Book Value Per Share	0.23
Working Capital	-242,327

Cash Flow

Operating Cash Flow	-13.61M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Genprex does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-69.37%
Shareholder Yield	-69.37%
Earnings Yield	-326.16%
FCF Yield	n/a

Stock Splits

The last stock split was on February 2, 2024. It was a reverse split with a ratio of 0.025.

Last Split Date	Feb 2, 2024
Split Type	Reverse
Split Ratio	0.025

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a